ArticleJournal of diabetes investigation2026

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital-based claims database.

Hiroshi Tsushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.